Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...

The latest COVID-19 treatment, using an inhibitor of the Fas ligand (FasL), also known as CD95 ligand (CD95L), speeds up ...

This aberrant increase in cell death causes lymphopenia ... I am therefore confident that our approach should be effective ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...

In addition, annual estimates of RSV-associated ICU admissions ranged from 24,400 to 34,900 for the 2016-2017 and 2017-2018 ...

Bacterial infection causes sepsis, an uncontrolled inflammatory response that leads to multiple organ dysfunction and death. Multi-drug resistant bacterial ... infectious diseases such as Influenza, ...

This aberrant increase in cell death causes lymphopenia ... I am therefore confident that our approach should be effective not only during future outbreaks of SARS-CoV-2 variants of concern, but ...

Discover six exosome therapy companies developing these tiny extracellular vesicles to treat an array of diseases.

The role of vaccines in preventing severe disease or death has been well-established scientifically ... The killing streak of ...

Explore the serious risks of long COVID and its potential impact on health. Can lingering symptoms from COVID-19 be fatal?

Paxlovid significantly shortened the time to symptom relief (median, 13 vs 15 days; hazard ratio [HR], 1.27) and resolution ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...